| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |